Related Experiment Video
Updated: Sep 25, 2025
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
A robust preparation method for the amyloidogenic and intrinsically disordered amyloid-α peptide
Ariel J Kuhn1, Jevgenij A Raskatov1
1Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA, USA.
Abstract:
Recent findings suggest that amyloid-β (Aβ) may not be the only peptidic culprit for the cognitive decline observed in patients with Alzheimer's disease. A C-terminal fragment of Aβ, amyloid-α (Aα), also known as p3, has been shown to form amyloidogenic oligomers and fibrils more rapidly than Aβ. However, the insolubility and aggregation propensity of this 24-26-residue peptide make it exceptionally difficult to produce, purify, and subsequently study. This paper reports a reproducible, multi-step method for the purification and pre-treatment of Aα and related analogues, yielding 95%-99% pure peptides. We anticipate that the methods described herein will permit previously inaccessible biophysical and biological experiments that may be critical to understanding the role of this too long overlooked peptide in AD disease pathology.
Insights
Amyloid-alpha (Aα), a peptide fragment, may contribute to Alzheimer's disease (AD) cognitive decline. This study presents a new method to purify Aα, enabling further research into its role in AD pathology.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Alzheimer's disease (AD) pathology is linked to amyloid-beta (Aβ) peptides.
- A C-terminal fragment of Aβ, amyloid-alpha (Aα) or p3, forms amyloidogenic species rapidly.
- Aα's insolubility and aggregation hinder its study.
Purpose of the Study:
- To develop a reproducible method for purifying amyloid-alpha (Aα) and its analogues.
- To enable critical biophysical and biological experiments on Aα.
- To investigate the role of Aα in Alzheimer's disease pathology.
Main Methods:
- A multi-step purification protocol was established for Aα peptides.
- Peptide pre-treatment methods were optimized.
- Purity of the resulting peptides was assessed.
Main Results:
- The developed method yields highly pure Aα peptides (95%-99%).
- The protocol is reproducible for Aα and related analogues.
- The purification challenges associated with Aα aggregation have been overcome.
Conclusions:
- The described method facilitates the study of amyloid-alpha (Aα).
- This advancement may be crucial for understanding Aα's role in Alzheimer's disease.
- Further biophysical and biological research on Aα is now feasible.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
01:25Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...